search
Back to results

Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF) (ACIDOFIV)

Primary Purpose

Embryo Growth Disorder, Humans, Pregnancy

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
pH at 7.38 ± 0.02
pH at 7.22 ± 0.02
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Embryo Growth Disorder focused on measuring pH, embryo culture, In Vitro Fertilization, live birth rate, randomized trial

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Couples whose woman is 18 to 40 years old and man is 18 to 60 at the time of inclusion.
  • Infertile couple with a medical indication of IVF-ICSI according to criteria applied in each center.
  • First or second ICSI attempt with fresh embryo transfer.
  • Signature of informed consent by both partners of the couple
  • Affiliation to a social security scheme or equivalent for both partners of the couple.
  • Fitting the inclusion criteria for IVF according the the French law.

Exclusion Criteria:

  • Use of spermatozoa extracted by testicular biopsy.
  • Freeze-al strategy (without fresh embryo transfer) decided before embryo culture
  • Absence of mature oocyte (metaphase II) at the day of the puncture
  • Uterine pathology affecting implantation (uterine malformation, diffuse adenomyosis ...)
  • One of the two partners (or both) is (are) infected with HIV, HCV or HBV in the year before the inclusion
  • One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.
  • Couple having already participated once in the study.
  • Couple enrolled in another interventional clinical study

Sites / Locations

  • CHU de BORDEAUXRecruiting
  • Centre AMP BIOPYRENEESRecruiting
  • CHU de TOULOUSERecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

pH 7.38 ± 0.02

pH 7.22 ± 0.02

Arm Description

IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the culture of the oocytes and embryos in the culture medium with a pH at 7.38 ± 0.02

IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the culture of the oocytes and embryos in the culture medium with a pH at 7.22 ± 0.02

Outcomes

Primary Outcome Measures

Live birth delivery rate
Number of deliveries that resulted in at least one live birth (gestational age ≥ 22 weeks) / Number of oocyte retrievals

Secondary Outcome Measures

Fertilization rate
Number of 2PN zygotes at day 1 post-injection / Number of matures injected oocytes
Cleavage rate
Number of embryos with at least 2 blastomeres at day 2 / Number of diploid zygotes at day 1 post-injection
Percentage of top embryos
Number of 7 to 10-blastomeres embryos at day 3 with less than 10% fragments / Total number of embryos at day 3
Embryo freezing rate
Number of frozen embryos / Total number of obtained embryos
Implantation rate
Number of gestational sacs observed with ultrasonography (5 weeks after embryo transfer) divided by the number of embryos transferred (expressed as a percentage)
Clinical ongoing pregnancy rate by transfer
Number of pregnancies diagnosed by ultrasonographic of at least one fetus with a discernible heartbeat at 5 weeks after embryo transfer / Number of embryo transfers
Clinical ongoing pregnancy rate by oocyte retrieval
Number of pregnancies diagnosed by ultrasonographic of at least one fetus with a discernible heartbeat at 5 weeks after embryo transfer / Number of oocyte retrieval
Miscarriage rate
Number of spontaneous loss of an intrauterine pregnancy prior to 22 completed weeks of gestational age / Number of pregnancies
Malformation rate diagnosed at birth
Number of malformations according to Eurocat classification (in total and in Eurocat subgroups) / Total number of newborns

Full Information

First Posted
June 29, 2020
Last Updated
August 25, 2023
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT04456478
Brief Title
Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF)
Acronym
ACIDOFIV
Official Title
Randomized Trial in Assisted Reproductive Technology : Impact of pH Values of the Embryo Culture Medium on Live Birth Rate After In Vitro Fertilization (IVF)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 14, 2020 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
April 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this study is to compare, through a multicentric randomized trial, the impact of two pH values in the embryo culture medium on the clinical results of In Vitro Fertilization (IVF) process and especially the impact on live birth delivery rate.
Detailed Description
Despite progress in Assisted Reproductive Technology (ART), the livebirth rate per oocyte retrieval during In Vitro Fertilization (IVF) remain relatively low (15 à 25%). This is in part due to the sensitivity of the preimplantation embryo to its environment. Indeed, there is growing evidence that culture conditions during IVF are critical not only for the development of pre- and post-implantation embryo, but also for long-term health effects; and numerous animal data suggest the importance of pH control in the IVF culture medium. Maintaining the intercellular pH (pHi) is one of the vital roles of embryo homeostasis since pHi regulates many cellular processes. Indeed, variations in pHi can affect embryonic development. Although the embryo has biochemical systems to regulate its pHi, these systems can be overtaken. Under the conditions of IVF embryo culture, the extracellular pH (pHe) in a culture medium is the result of a balance between CO2 concentration in the incubator and bicarbonate concentration in the culture medium (determined by the medium manufacturer). The recommendations of the manufacturers of embryo culture media are to maintain a pHe slightly higher (generally between 7.2 and 7.4) than the pHi (estimated between 7.1 to 7.2) to compensate for the acidification due to cell metabolism. However, as the pH scale is logarithmic, a pHe variation of 7.2 to 7.4 corresponds to a decrease in the concentration of H+ ions by a factor of 1.6 in the medium. Actually, there is no clinical data to know what is the ideal pH to apply to a culture medium during IVF. This is a clinical study comparing two pH values in the culture medium of embryos obtained by IVF, randomized, multicentric (3 centers), patient-blinded, in groups parallel to the ratio 1: 1. IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the 1: 1 randomization: culture of the oocytes and embryos in the culture medium with a pH at 7.38 ± 0.02 or a pH at 7.22 ± 0.02. In case of pregnancy after embryo transfer, patients will be followed until delivery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Embryo Growth Disorder, Humans, Pregnancy
Keywords
pH, embryo culture, In Vitro Fertilization, live birth rate, randomized trial

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multicentric randomized blinded trial
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
622 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
pH 7.38 ± 0.02
Arm Type
Active Comparator
Arm Description
IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the culture of the oocytes and embryos in the culture medium with a pH at 7.38 ± 0.02
Arm Title
pH 7.22 ± 0.02
Arm Type
Experimental
Arm Description
IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the culture of the oocytes and embryos in the culture medium with a pH at 7.22 ± 0.02
Intervention Type
Procedure
Intervention Name(s)
pH at 7.38 ± 0.02
Intervention Description
In the 3 centers of the study, IVF-ICSI will be performed according to the usual procedure: ovarian stimulation, oocyte retrieval, sperm microinjection by ICSI, embryo culture in Global® Total HSA medium, embryo selection and transfer at day 3. The day of the oocyte puncture, the embryologist will proceed to the 1: 1 randomization: culture of the embryos in a medium with a pH at 7.38 ± 0.02. We have chosen to study specifically the early stages of fertilization and embryo development (until day 3), stages for which extracellular pH control is more critical because the intracellular pH regulatory mechanisms are somewhat limited and could be exceeded.
Intervention Type
Procedure
Intervention Name(s)
pH at 7.22 ± 0.02
Intervention Description
In the 3 centers of the study, IVF-ICSI will be performed according to the usual procedure: ovarian stimulation, oocyte retrieval, sperm microinjection by ICSI, embryo culture in Global® Total HSA medium, embryo selection and transfer at day 3. The day of the oocyte puncture, the embryologist will proceed to the 1: 1 randomization: culture of the embryos in a medium with a pH at 7.22 ± 0.02. We have chosen to study specifically the early stages of fertilization and embryo development (until day 3), stages for which extracellular pH control is more critical because the intracellular pH regulatory mechanisms are somewhat limited and could be exceeded.
Primary Outcome Measure Information:
Title
Live birth delivery rate
Description
Number of deliveries that resulted in at least one live birth (gestational age ≥ 22 weeks) / Number of oocyte retrievals
Time Frame
month 9
Secondary Outcome Measure Information:
Title
Fertilization rate
Description
Number of 2PN zygotes at day 1 post-injection / Number of matures injected oocytes
Time Frame
day 1
Title
Cleavage rate
Description
Number of embryos with at least 2 blastomeres at day 2 / Number of diploid zygotes at day 1 post-injection
Time Frame
day 2
Title
Percentage of top embryos
Description
Number of 7 to 10-blastomeres embryos at day 3 with less than 10% fragments / Total number of embryos at day 3
Time Frame
day 3
Title
Embryo freezing rate
Description
Number of frozen embryos / Total number of obtained embryos
Time Frame
day 6
Title
Implantation rate
Description
Number of gestational sacs observed with ultrasonography (5 weeks after embryo transfer) divided by the number of embryos transferred (expressed as a percentage)
Time Frame
week 5
Title
Clinical ongoing pregnancy rate by transfer
Description
Number of pregnancies diagnosed by ultrasonographic of at least one fetus with a discernible heartbeat at 5 weeks after embryo transfer / Number of embryo transfers
Time Frame
week 5
Title
Clinical ongoing pregnancy rate by oocyte retrieval
Description
Number of pregnancies diagnosed by ultrasonographic of at least one fetus with a discernible heartbeat at 5 weeks after embryo transfer / Number of oocyte retrieval
Time Frame
week 5
Title
Miscarriage rate
Description
Number of spontaneous loss of an intrauterine pregnancy prior to 22 completed weeks of gestational age / Number of pregnancies
Time Frame
week 22
Title
Malformation rate diagnosed at birth
Description
Number of malformations according to Eurocat classification (in total and in Eurocat subgroups) / Total number of newborns
Time Frame
month 9

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Couples whose woman is 18 to 40 years old and man is 18 to 60 at the time of inclusion because the study concerns in vitro fertilization
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Couples whose woman is 18 to 40 years old and man is 18 to 60 at the time of inclusion. Infertile couple with a medical indication of IVF-ICSI according to criteria applied in each center. First or second ICSI attempt with fresh embryo transfer. Signature of informed consent by both partners of the couple Affiliation to a social security scheme or equivalent for both partners of the couple. Fitting the inclusion criteria for IVF according the the French law. Exclusion Criteria: Use of spermatozoa extracted by testicular biopsy. Freeze-al strategy (without fresh embryo transfer) decided before embryo culture Absence of mature oocyte (metaphase II) at the day of the puncture Uterine pathology affecting implantation (uterine malformation, diffuse adenomyosis ...) One of the two partners (or both) is (are) infected with HIV, HCV or HBV in the year before the inclusion One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship. Couple having already participated once in the study. Couple enrolled in another interventional clinical study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicolas GATIMEL, ph
Phone
05 67 77 10 08
Ext
33
Email
gatimel.n@chu-toulouse.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolas GATIMEL, ph
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de BORDEAUX
City
Bordeaux
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aline PAPAXANTHOS, PH
Phone
0556795681
Ext
33
Email
aline.papaxanthos@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Aline PAPAXANTHOS, ph
Facility Name
Centre AMP BIOPYRENEES
City
Pau
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven CENS, ph
Phone
0559275131
Ext
33
Email
steven.cens@biopyrenees.com
First Name & Middle Initial & Last Name & Degree
Steven CENS, ph
Facility Name
CHU de TOULOUSE
City
Toulouse
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicolas GATIMEL, PH
Phone
05 67 77 10 08
Ext
33
Email
gatimel.n@chu-toulouse.fr
First Name & Middle Initial & Last Name & Degree
Célia BETTIOL
Phone
05.67.77.13.87
Ext
33
Email
bettiol.c@chu-toulouse.fr
First Name & Middle Initial & Last Name & Degree
Nicolas GATIMEL, PH

12. IPD Sharing Statement

Learn more about this trial

Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF)

We'll reach out to this number within 24 hrs